EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Reduced Complement and Granulocyte Activation by α‐Gal Knockout Porcine Pericardium for Bioprosthetic Heart Valves: A Pilot Hemocompatibility Study

Claudia Dittfeld iD, Elisabeth Kemter iD, Barbara Kessler, Eckhard Wolf iD, Anett Jannasch iD, Claudia Sperling, Sems-Malte Tugtekin, Manfred F Maitz iD

Journal of Biomedical Materials Research Part A · 2026-07 · 114 (7)

DOI: 10.1002/jbm.a.70114 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biomedical Materials Research Part A, online erschienen am 15.07.2026. Verfasst von Claudia Dittfeld und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiac Surgery, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Heart Centre Dresden, D…. Hauptthemen laut MEDLINE: Pericardium, Bioprosthesis, Heart Valve Prosthesis, Complement Activation. Die Arbeit nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, Fondation Leducq.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Xenogeneic pericardium is the main source for biological aortic valve prostheses. Immune responses to α‐Gal epitopes and free aldehyde groups after glutaraldehyde (GA) fixation are responsible for the graft deterioration and the need for reoperation. Genetically modified α‐Gal‐depleted porcine pericardium is evaluated in this pilot study as an alternative to avoid immunologic interactions and prevent degeneration. The absence of α‐Gal epitopes was confirmed by both anti‐α‐Gal and IB4 isolectin staining in α‐Gal‐KO pericardia. Elastic Moduli, collagen and elastin composition, and in vitro calcification susceptibility were similar irrespective of the pericardium donor genotype. For testing the response of an α‐Gal‐negative recipient organism, incubation assays with human whole blood were performed. Native α‐Gal‐KO pericardium induced a lower inflammatory blood response than tissue without modification, regarding complement granulocyte activation. GA fixation enhanced the inflammatory response for both tissue types, but the lower granulocyte activation persisted for the α‐Gal‐KO tissue. Thrombogenicity, regarding coagulation cascade and platelet activation, was not affected by the genetic modification. Native tissues induced high activation of the coagulation cascade, attributed to tissue factor activity, which was abrogated by the GA fixation. Cell and fibrin deposits on the pericardia corroborated the blood phase observations. It is concluded that the distinct lower inflammatory potential of the α‐Gal‐KO pericardium makes it an attractive tissue for artificial heart valves; however, it requires a preparation method with sufficient inactivation of procoagulant tissue factor activity without providing an inflammatory stimulus. Prospectively, the removal of additional xeno‐epitopes like Neu5Gc can be considered to reduce the inflammatory potential further.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PericardiumBioprosthesisHeart Valve ProsthesisComplement ActivationGranulocytesMaterials TestingGene Knockout TechniquesAnimalsPilot ProjectsHumansSwineGlutaral

Stichwörter der Autor:innen

biological aortic valve prosthesesgenetic modificationhemocompatibilityinflammationporcine pericardiumtissue propertiesα‐Gal

Substanzen

Glutaral

Autor:innen und Institutionen

  • Department of Cardiac Surgery, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Heart Centre Dresden, Dresden, Germany.
  • Chair of Molecular Animal Breeding and Biotechnology, Gene Center, and Center for Innovative Medical Models, LMU Munich, Germany.
  • Leibniz-Institut für Polymerforschung Dresden e.V., Division Polymer Biomaterials Science, Dresden, Germany.

ORCID-Profile: Claudia Dittfeld, Elisabeth Kemter, Eckhard Wolf, Anett Jannasch, Manfred F Maitz

Förderung

  • Deutsche Forschungsgemeinschaft
  • Fondation Leducq

Zitieren

APA

Dittfeld, C., Kemter, E., Kessler, B., Wolf, E., Jannasch, A., Sperling, C., Tugtekin, S. M., & Maitz, M. F. (2026). Reduced Complement and Granulocyte Activation by α‐Gal Knockout Porcine Pericardium for Bioprosthetic Heart Valves: A Pilot Hemocompatibility Study. Journal of Biomedical Materials Research Part A, 114(7). https://doi.org/10.1002/jbm.a.70114

Vancouver

Dittfeld C, Kemter E, Kessler B, Wolf E, Jannasch A, Sperling C, et al. Reduced Complement and Granulocyte Activation by α‐Gal Knockout Porcine Pericardium for Bioprosthetic Heart Valves: A Pilot Hemocompatibility Study. Journal of Biomedical Materials Research Part A. 2026;114(7). doi:10.1002/jbm.a.70114

BibTeX
@article{Dittfeld2026,
  author = {Dittfeld, Claudia and Kemter, Elisabeth and Kessler, Barbara and Wolf, Eckhard and Jannasch, Anett and Sperling, Claudia and Tugtekin, Sems-Malte and Maitz, Manfred F},
  title = {Reduced Complement and Granulocyte Activation by α‐Gal Knockout Porcine Pericardium for Bioprosthetic Heart Valves: A Pilot Hemocompatibility Study},
  journal = {Journal of Biomedical Materials Research Part A},
  year = {2026},
  volume = {114},
  number = {7},
  doi = {10.1002/jbm.a.70114}
}
Kostenlos starten →